125 related articles for article (PubMed ID: 36660986)
1. Clinical course, long-term outcomes, and chemotherapy toxicity profile in B-cell Non-Hodgkin Lymphoma in children: Single institution experience of Pakistan.
Rehman P; Wali RM
J Pak Med Assoc; 2022 Oct; 72(10):1988-1993. PubMed ID: 36660986
[TBL] [Abstract][Full Text] [Related]
2. Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan.
Faizan M; Anwar S; Khan S
J Coll Physicians Surg Pak; 2018 Jan; 28(1):48-51. PubMed ID: 29290192
[TBL] [Abstract][Full Text] [Related]
3. Outcome of first relapse of Hodgkin lymphoma: single institution experience.
Shaheen N; Maaz AUR; Khan MS
J Pak Med Assoc; 2021 Mar; 71(3):883-888. PubMed ID: 34057940
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan.
Mehreen A; Wali RM; Sindhu II; Asad M; Ria S
J Pak Med Assoc; 2019 Sep; 69(9):1266-1272. PubMed ID: 31511710
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics And Treatment Outcome Of Paediatric Non-Hodgkin's Lymphoma At A Tertiary Care Hospital In Pakistan.
Naqvi J; Sajid MI; Khan S; Nisa Kamran ZU; Fadoo Z
J Pak Med Assoc; 2023 Nov; 73(11):2161-2164. PubMed ID: 38013521
[TBL] [Abstract][Full Text] [Related]
6. Impact of rituximab and IPI on survival in diffuse large B cell lymphoma patients treated at a tertiary level cancer centre in Pakistan: a single-centre experience.
Athar S; Siddiqui N; Rai SR; Muzaffar N; Hameed A
J Pak Med Assoc; 2015 Feb; 65(2):170-4. PubMed ID: 25842553
[TBL] [Abstract][Full Text] [Related]
7. Death analysis of childhood acute lymphoblastic leukaemia; experience at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan.
Asim M; Zaidi A; Ghafoor T; Qureshi Y
J Pak Med Assoc; 2011 Jul; 61(7):666-70. PubMed ID: 22204242
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
[TBL] [Abstract][Full Text] [Related]
9. Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
Toogood IR; Tiedemann K; Stevens M; Smith PJ
Med Pediatr Oncol; 1993; 21(2):103-10. PubMed ID: 8433675
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Presentation and Outcome in 100 Pediatric Hodgkin Lymphoma Patients Treated at Children Hospital, Lahore, Pakistan and Royal Marsden Hospital, UK.
Faizan M; Taj MM; Anwar S; Asghar N; Ahmad A; Lancaster D; Atra A; Ali AS
J Coll Physicians Surg Pak; 2016 Nov; 26(11):904-907. PubMed ID: 27981925
[TBL] [Abstract][Full Text] [Related]
11. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
12. Non-Hodgkin lymphoma after liver and kidney transplantation in children. Experience from one center.
Dembowska-Bagińska B; Wakulińska A; Daniluk I; Teisseyre J; Jankowska I; Czubkowski P; Grenda R; Jarmużek W; Grajkowska W; Małdyk J; Kaliciński P
Adv Clin Exp Med; 2020 Feb; 29(2):197-202. PubMed ID: 32154678
[TBL] [Abstract][Full Text] [Related]
13. Pediatric non-Hodgkin lymphoma: Characteristics, stratification, and treatment at a single institute in Thailand.
Choeyprasert W; Anurathapan U; Pakakasama S; Sirachainan N; Songdej D; Lertthammakiat S; Hongeng S
Pediatr Int; 2019 Jan; 61(1):49-57. PubMed ID: 30734424
[TBL] [Abstract][Full Text] [Related]
14. [Outcomes of 104 children with B-cell non-Hodgkin lymphoma].
Ye QD; Pan C; Xue HL; Chen J; Zhou M; Jiang H; Shen SH; Tang YJ; Wang JM
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):399-403. PubMed ID: 23688749
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's lymphoma in Pakistan: a clinico-epidemiological study of 658 cases at a cancer center in Lahore.
Siddiqui N; Ayub B; Badar F; Zaidi A
Asian Pac J Cancer Prev; 2006; 7(4):651-5. PubMed ID: 17250446
[TBL] [Abstract][Full Text] [Related]
17. Pediatric lymphoma: a 10-year experience at a tertiary care hospital in Pakistan.
Fadoo Z; Belgaumi A; Alam M; Azam I; Naqvi A
J Pediatr Hematol Oncol; 2010 Jan; 32(1):e14-8. PubMed ID: 20051771
[TBL] [Abstract][Full Text] [Related]
18. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group.
Attarbaschi A; Dworzak M; Steiner M; Urban C; Fink FM; Reiter A; Gadner H; Mann G
Pediatr Blood Cancer; 2005 Jan; 44(1):70-6. PubMed ID: 15368550
[TBL] [Abstract][Full Text] [Related]
19. Outcome of pediatric non-Hodgkin lymphoma in Central America: A report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA).
Peña-Hernandez A; Ortiz R; Garrido C; Gomez-Garcia W; Fuentes-Alabi S; Martinez R; Metzger ML; Chantada GL; Ribeiro RC
Pediatr Blood Cancer; 2019 May; 66(5):e27621. PubMed ID: 30677231
[TBL] [Abstract][Full Text] [Related]
20. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials.
Seidemann K; Tiemann M; Henze G; Sauerbrey A; Müller S; Reiter A
Med Pediatr Oncol; 1999 Dec; 33(6):536-44. PubMed ID: 10573576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
